Table 1 List of genes examined in this study.
From: Gene expression changes following extinction testing in a heroin behavioral incubation model
Abbreviation | Gene Name | Accession # | Assay ID |
|---|---|---|---|
BDNF | Brain derived neurotropic factor | NM_012513 | Rn02531967_s1 |
Ctnnb1 | Catenin, beta 1 | NM_053357 | Rn00584431_g1 |
Calb1 | Calbindin 1 | NM_031984 | Rn00583140_m1 |
Cdkn1b | Cyclin-dependent kinase inhibitor 1B | NM_031762 | Rn00582195_m1 |
Chka | Choline kinase alpha | NM_017127 | Rn00567492_m1 |
Cited2 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | NM_053698 | Rn00586705_m1 |
Crk | v-crk sarcoma virus oncogene homolog | NM_019302 | Rn00467066_m1 |
Dusp5 | Dual specificity phosphatase 5 | NM_133578 | Rn00592122_m1 |
Dusp6 | Dual specificity phosphatase 6 | NM_053883 | Rn00518185_m1 |
Fmr1 | Fragile X mental retardation syndrome 1 homolog | NM_052804 | Rn00709627_m1 |
Glud1 | Glutamate dehydrogenase 1 | NM_012570 | Rn00561306_m1 |
Gria2 | Glutamate receptor, ionotropic, AMPA2 | NM_017261 | Rn00568514_m1 |
Hif1a | Hypoxia inducible factor 1, alpha subunit | NM_024359 | Rn00577560_m1 |
Myst2 | MYST histone acetyltransferase 2 | NM_181081 | Rn00710321_m1 |
Npy | Neuropeptide Y | NM_012614 | Hs00173470_m1 |
Npy5r | Neuropeptide Y receptor Y5 | NM_012869 | Rn02089867_s1 |
Slit2 | Slit homolog 2 | NM_022632 | Rn00575268_m1 |
Rgs2 | Regulator of G-protein signaling 2 | NM_053453 | Rn00584932_m1 |
Wasl | Wiskott-Aldrich syndrome-like (human) | NM_001034130 | Rn01501132_m1 |